REVEAL GENOMICS® ANNOUNCES POSITIVE TOP-LINE RESULTS FOR HER2DX® IN MEDSIR’S PHERGAIN TRIAL
(Adnkronos) – BARCELONA, Spain, June 15, 2023 /PRNewswire/ — REVEAL GENOMICS, S.L., a Barcelona-based biotech start-up seeking to revolutionize precision oncology through diagnostic innovation, today announced another validation of HER2DX®, the world’s first
